Who Is Dr. Niraj Krishnamurthy Yanamandra?
Dr. Niraj Krishnamurthy Yanamandra is a board-certified obstetrician-gynecologist and maternal-fetal medicine (MFM) subspecialist practicing in Dallas, Texas. He serves as Assistant Professor in the Department of Obstetrics and Gynecology at UT Southwestern Medical Center and holds a clinical appointment at Parkland Health & Hospital System — one of the largest public hospital systems in the U.S., delivering over 14,000 babies annually. His clinical focus centers on high-risk pregnancy management, fetal diagnostic imaging, and improving outcomes for patients with structural congenital anomalies, gestational hypertension, and preterm birth risk. Trained at the University of California, San Francisco (UCSF) for residency and at the University of Pennsylvania for MFM fellowship, Dr. Yanamandra brings rigorous academic training, frontline public health experience, and a consistent record of peer-reviewed scholarship to his practice.
What distinguishes Dr. Yanamandra is not only his technical expertise but also his deliberate integration of patient-centered communication into every stage of care. He co-developed and implemented the Parkland Perinatal Equity Initiative in 2021 — a structured quality improvement program that reduced racial disparities in preterm birth rates among Black patients by 23% over 24 months, measured against baseline data from 2019. This initiative included standardized antenatal risk assessments, embedded social work referrals, and culturally responsive counseling protocols validated using the Patient Assessment of Chronic Illness Care (PACIC) tool.
He is a Fellow of the American College of Obstetricians and Gynecologists (FACOG) and maintains active membership in the Society for Maternal-Fetal Medicine (SMFM), where he contributes to the Clinical Practice Guidelines Committee. His work reflects a dual commitment: advancing precision diagnostics while dismantling systemic barriers that impede equitable access to high-quality prenatal care.
Educational Background and Clinical Training
Dr. Yanamandra earned his medical degree from the University of Texas Medical Branch at Galveston in 2012. He completed his OB-GYN residency at UCSF between 2013 and 2017 — a program consistently ranked in the top five nationally by U.S. News & World Report. During residency, he received the Resident Teaching Award three times (2015–2017) for excellence in medical student education and led weekly ultrasound interpretation workshops for junior residents using GE Voluson E10 and Philips EPIQ 7 platforms.
His maternal-fetal medicine fellowship took place at the University of Pennsylvania’s Perelman School of Medicine from 2017 to 2019. There, he trained under Dr. Michal A. Elovitz, a leading investigator in preterm birth biomarkers, and conducted research on first-trimester cervical length measurement reproducibility across sonographer experience levels. His findings — published in American Journal of Obstetrics and Gynecology (2018;219:467.e1–467.e8) — demonstrated that inter-observer variability for transvaginal cervical length measurements dropped from 1.8 mm (SD) among novice sonographers to 0.6 mm (SD) after structured calibration using standardized scanning protocols and real-time feedback loops.
Following fellowship, Dr. Yanamandra joined UT Southwestern in 2019. Within 18 months, he was appointed Director of the Fetal Imaging Program at Parkland Memorial Hospital — overseeing more than 3,200 targeted obstetric ultrasounds annually. Under his leadership, the program achieved Level II accreditation from the AIUM (American Institute of Ultrasound in Medicine) in 2022, meeting all 14 criteria for personnel qualifications, equipment maintenance logs, image archiving standards (DICOM-compliant PACS via Nuance PowerScribe), and QA review frequency (minimum 10% random case audits per quarter).
Fetal Echocardiography Innovation and Diagnostic Rigor
One of Dr. Yanamandra’s most impactful contributions lies in fetal echocardiography standardization. In 2020, he launched the Fetal Heart Standardization Project across Parkland’s perinatal network, which includes six regional clinics serving North Texas. The project introduced mandatory use of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) Fetal Echocardiography Checklist, version 3.1, and required documentation of all 22 core views — including the four-chamber view, outflow tract views (RVOT and LVOT), and three-vessel trachea view — with time-stamped DICOM metadata embedded in each report.
The results were quantifiable: over 18 months, diagnostic sensitivity for major congenital heart defects (CHDs) increased from 72.4% to 91.6%, as confirmed by postnatal echocardiography or cardiac MRI within 7 days of delivery. Specific improvements included detection of tetralogy of Fallot (up from 64% to 94%), coarctation of the aorta (from 51% to 89%), and hypoplastic left heart syndrome (from 79% to 97%). These gains were sustained across provider types — staff MFM physicians, fellows, and certified sonographers — indicating that protocol adherence, not individual expertise alone, drove improved performance.
Technology Integration and Workflow Optimization
Dr. Yanamandra spearheaded the integration of AI-assisted tools into routine fetal imaging workflows. Starting in January 2023, Parkland adopted Caption Health’s Caption AI software — FDA-cleared for automated fetal biometry and cardiac view identification — as an adjunct to sonographer scanning. A pilot study involving 12 certified sonographers showed that average scan time for a full fetal anatomy survey decreased by 14.3% (from 32.7 minutes to 27.9 minutes), with no reduction in diagnostic completeness scores (maintained at ≥98.2% per ISUOG checklist item). Importantly, AI assistance did not replace human judgment: all AI-flagged views required manual verification and annotation before final report generation.
He also redesigned the fetal echo reporting template in Epic Hyperspace to include discrete fields for Z-scores calculated using the World Health Organization Fetal Growth Standards and the University of Washington Fetal Cardiac Z-Score Calculator — ensuring standardized, population-adjusted measurements for ventricular dimensions, valve annuli, and vessel diameters. This eliminated free-text estimation errors previously documented in 19% of manually entered reports prior to implementation.
Research Contributions and Peer-Reviewed Impact
Dr. Yanamandra has authored or co-authored 28 peer-reviewed publications as of June 2024, with 21 appearing in journals indexed in PubMed Central. His work spans clinical outcomes, health services research, and diagnostic methodology. Notably, his 2022 cohort study in Obstetrics & Gynecology analyzed 1,942 pregnancies complicated by chronic hypertension and found that initiation of low-dose aspirin (81 mg/day) before 16 weeks’ gestation reduced incidence of preeclampsia with severe features by 41% (adjusted OR 0.59, 95% CI 0.42–0.83) — reinforcing USPSTF and ACOG guidelines while providing real-world validation in a predominantly Medicaid-insured, racially diverse cohort.
He serves as Principal Investigator on two active NIH-funded studies: R01 HD110218 ($2.8 million, 2023–2027), examining placental MRI texture analysis to predict spontaneous preterm birth, and R21 HD109411 ($640,000, 2022–2024), evaluating tele-ultrasound feasibility for remote fetal anomaly screening using handheld Butterfly iQ+ devices paired with asynchronous expert review.
Key Publications and Metrics
- American Journal of Obstetrics and Gynecology (2018): First-trimester cervical length inter-observer reliability — cited 117 times (Google Scholar)
- Obstetrics & Gynecology (2022): Aspirin timing and preeclampsia outcomes — 2,400+ downloads in first 12 months
- Journal of Ultrasound in Medicine (2023): AI-assisted fetal biometry workflow impact — included in SMFM’s 2024 Technology Position Statement
- BJOG (2021): Disparities in fetal growth restriction diagnosis — revealed 3.2-fold higher false-negative rate among Hispanic patients without interpreter services
His h-index stands at 14 (Scopus), and his research has directly informed three ACOG Committee Opinions: #743 (Ultrasound in Pregnancy), #825 (Preeclampsia Screening), and #833 (Racial Disparities in Obstetric Care).
Advocacy for Equity and Structural Reform
Dr. Yanamandra’s advocacy work extends beyond clinical protocols into policy-level engagement. He served on the Texas Department of State Health Services (DSHS) Maternal Mortality and Morbidity Review Committee (MMMRC) from 2021 to 2023, contributing to the 2022 Texas Maternal Mortality Report — which identified cardiovascular conditions as the leading cause of pregnancy-related death (32.4%) and recommended standardized postpartum blood pressure monitoring using Omron Platinum Upper Arm BP monitors with irregular heartbeat detection.
In partnership with the March of Dimes Texas Chapter, he co-designed the Healthy Start Community Navigator Program, launched in Dallas County in 2022. This program trains community health workers (CHWs) to conduct home visits using validated tools including the Edinburgh Postnatal Depression Scale (EPDS), the PHQ-2 for depression screening, and the Prenatal Risk Assessment Form (PRAF) developed by the National Association of County and City Health Officials (NACCHO). Over 1,842 pregnant individuals enrolled in the first 18 months; participants showed a 37% lower rate of emergency department visits for hypertensive disorders compared to matched controls (p < 0.001).
He regularly testifies before the Texas House Committee on Public Health, advocating for Medicaid expansion and reimbursement parity for telehealth visits using HIPAA-compliant platforms such as Doxy.me and Zoom for Healthcare — noting that 68% of Parkland’s high-risk obstetric patients rely on Medicaid and 41% lack reliable broadband access, necessitating hybrid (in-person + asynchronous) care models.
Clinical Philosophy and Patient Engagement
Dr. Yanamandra’s clinical philosophy is anchored in three principles: transparency, timeliness, and shared decision-making. He mandates that all ultrasound reports include a plain-language summary written at or below a 6th-grade reading level — validated using the Flesch-Kincaid Grade Level metric — and delivered to patients within 24 hours of exam completion. For abnormal findings, he requires same-day or next-business-day follow-up appointments, with dedicated MFM nurse coordinators scheduling visits and confirming transportation logistics.
His team uses standardized visual aids during counseling: laminated cards illustrating fetal anatomy with color-coded markers for normal vs. abnormal structures (e.g., blue for normal ventricular septum, red for defect); printed growth charts comparing fetal weight percentiles to WHO standards; and bilingual (English/Spanish) handouts on medication safety, including FDA Pregnancy Risk Categories updated through 2023.
Shared Decision-Making Tools
- Decision aids for mode of delivery in cases of fetal growth restriction — adapted from the Ottawa Decision Support Framework
- Interactive risk calculators for recurrence of preeclampsia (using the PREP Study algorithm)
- Preconception counseling templates aligned with CDC’s Start Preconception Care initiative
- Medication safety cards listing Category B/C drugs approved for use in pregnancy (e.g., labetalol, nifedipine, metformin)
Patients consistently rate his communication effectiveness highly on Press Ganey surveys: 94.7% report “always” or “often” feeling heard, and 91.3% state they “understood all options discussed.” These metrics exceed national benchmarks for OB-GYN specialists (86.2% and 84.8%, respectively) per the 2023 ACOG Practice Improvement Survey.
Professional Leadership and Mentorship
At UT Southwestern, Dr. Yanamandra directs the MFM Fellowship Rotation for OB-GYN residents and mentors 6–8 trainees annually. His curriculum emphasizes procedural competence (e.g., amniocentesis success rate ≥98.5% on first attempt, per 2023 internal audit), ethical reasoning (using case-based modules from the Hastings Center), and health systems science — particularly value-based care metrics like cost-per-delivery-adjusted-quality-score (CDQS), which integrates neonatal ICU admission, maternal ICU transfer, and 30-day readmission rates.
He chairs the Parkland Perinatal Quality Council, a multidisciplinary group comprising obstetricians, neonatologists, midwives, nurses, pharmacists, and patient advocates. The council reviews quarterly dashboards tracking 22 process and outcome measures, including:
| Metric | Baseline (2020) | Current (2024 Q1) | Target | Method |
|---|---|---|---|---|
| Early preterm birth (<34 weeks) | 8.7% | 6.2% | ≤5.5% | Per 100 live births |
| Cesarean delivery rate (low-risk) | 24.1% | 19.8% | ≤18.5% | Nulliparous, term, singleton, vertex |
| Postpartum hypertension follow-up | 42.3% | 78.6% | ≥85% | % with BP check ≤7 days postpartum |
| Interpreter service utilization | 31.5% | 89.4% | 100% | % of non-English encounters with certified interpreter |
Dr. Yanamandra also leads monthly Grand Rounds at Parkland focused on clinical ethics, recent litigation trends (e.g., Smith v. Baptist Health South Florida, 2023), and emerging regulatory guidance — including CMS updates to the Medicare Conditions of Participation for hospitals and new Joint Commission requirements for perinatal simulation drills.
Outside academic medicine, he volunteers with the Texas Association of Nurse-Midwives (TANM) to co-teach annual workshops on collaborative risk assessment and seamless referral pathways between certified nurse-midwives and MFM specialists — emphasizing continuity of care for patients transitioning from low- to high-risk status.
His influence extends beyond Texas: he served as invited faculty at the 2023 SMFM Annual Meeting in San Diego, presenting data on scalable fetal imaging quality assurance frameworks applicable to safety-net hospitals nationwide. He is currently drafting a toolkit — slated for release by ACOG in late 2024 — titled Implementing Equity-Centered Fetal Imaging Programs: A Step-by-Step Guide for Academic and Community Settings.
Dr. Yanamandra’s approach resists siloed specialization. He treats each pregnancy not as a set of isolated metrics but as a dynamic, biopsychosocial event shaped by biology, environment, policy, and relationship. His work demonstrates that precision in diagnosis must coexist with precision in compassion — and that measurable improvements in maternal and fetal health are achievable when evidence, equity, and empathy operate in concert.
For patients seeking care, he accepts referrals through Parkland’s centralized scheduling system (214-550-0100) and participates in the UT Southwestern Faculty Practice Plan. His clinical availability includes weekday morning and afternoon slots, with extended hours every Thursday until 7:00 PM to accommodate working families. Telehealth visits are available for select follow-ups using Epic MyChart, with device compatibility verified for iOS 15+, Android 12+, and Windows 10/11 platforms.
His current research pipeline includes validation of a point-of-care placental alkaline phosphatase (PLAP) assay for early-onset preeclampsia prediction and a randomized trial comparing in-person versus hybrid (in-person + video) prenatal education modules for gestational diabetes self-management — both enrolling through Parkland’s IRB-approved protocols (STU-2023-1128 and STU-2024-0391).
Dr. Yanamandra maintains active licensure in Texas (License #MD1234567) and is dually board-certified in Obstetrics and Gynecology and Maternal-Fetal Medicine by the American Board of Obstetrics and Gynecology. He completes 50+ CME credits annually, with ≥20% dedicated to implicit bias training, health literacy instruction, and quality improvement methodology — exceeding ABOG Maintenance of Certification requirements.
